logo
welcome
Ars Technica

Ars Technica

How we went from paper chromosomes to today’s precision cancer drugs

Ars Technica
Summary
Nutrition label

87% Informative

Janet Rowley made the discovery that would dramatically alter the course of cancer research.

Rowley had the first evidence that genetic abnormalities were the cause of cancer.

By the mid-1990s , researchers had developed a drug that blocks the BCR -ABL protein, a tyrosine kinase inhibitor.